{"text": ["Jim", "Simons'", "Firm's", "Top", "Trades", "of", "the", "4th", "Quarter"], "created_at": "2021-02-22 21:38:11"}
{"text": ["AbbVie's", "Upadacitinib", "Shows", "Clinical", "Benefit", "In", "Second", "Late-Stage", "Ulcerative", "Colitis", "Study"], "created_at": "2021-02-22 17:29:42"}
{"text": ["Second", "Phase", "3", "Induction", "Study", "Confirms", "Upadacitinib", "(RINVOQ\u2122)", "Improved", "Clinical,", "Endoscopic", "and", "Histologic", "Outcomes", "in", "Ulcerative", "Colitis", "Patients"], "created_at": "2021-02-22 13:45:00"}
{"text": ["3", "Stocks", "to", "Buy", "with", "Dividends", "Yielding", "More", "than", "4%"], "created_at": "2021-02-22 13:13:00"}
